Search

Author/Creator Donnet, Valerie

1. Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre study. (July 2021)

Authors:
Curigliano, Giuseppe; Martin, Miguel; Jhaveri, Komal; Beck, J.T.; Tortora, Giampaolo; Fazio, Nicola; Maur, Michela; Hubner, Richard A.; Lahner, Harald; Donnet, Valerie; Ajipa, Olga; Li, Zheng; Blumenstein, Lars; Andre, Fabrice
Journal:
European journal of cancer
Issue:
Volume 151(2021)
Page Start:
49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study. Issue 4 (13th July 2020)

Authors:
Rosenthal, Mark; Clement, Paul M; Campone, Mario; Gil-Gil, Miguel J; DeGroot, John; Chinot, Olivier; Idbaih, Ahmed; Gan, Hui; Raizer, Jeffrey; Wen, Patrick Yung; Pineda, Estela; Donnet, Valerie; Mills, David; El-Hashimy, Mona; Mason, Warren
Journal:
ESMO open
Issue:
Volume 5:Issue 4(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma. Issue 4 (12th July 2020)

Authors:
Wen, Patrick Yung; Rodon, Jordi A; Mason, Warren; Beck, Joseph T; DeGroot, John; Donnet, Valerie; Mills, David; El-Hashimy, Mona; Rosenthal, Mark
Journal:
ESMO open
Issue:
Volume 5:Issue 4(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search